Galena Biopharma Inc (NASDAQ:GALE)

1.57
Delayed Data
As of May 29
 -0.06 / -3.68%
Today’s Change
1.27
Today|||52-Week Range
3.58
+3.97%
Year-to-Date

Today’s Trading

Previous close1.63
Today’s open1.63
Day’s range1.56 - 1.65
Volume4,031,045
Average volume (3 months)3,225,304
Market cap$253.9M
Dividend yield--
Data as of 4:00pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)+10.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book5.49

Competitors

 Today’s
change
Today’s
% change
ECYTEndocyte Inc-0.06-0.98%
CORICorium International...+0.61+4.52%
TKAITokai Pharmaceutical...-0.02-0.18%
ZGNXZogenix Inc+0.21+14.09%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark W. Schwartz
Senior VP-Clinical Sciences &
Operations
Gavin S. Choy
Corporate headquarters
Portland, Oregon

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers